External open innovation partner programSearch and explore self-detection applications for thyroid diseases to be used by general public to increase the awareness and to shorten the time until confirmative diagnosis.
Open for every kind of technology including mobile applications and games, other technology solutions including guidance or gamifications for self-detection of the thyroid function to increase the awareness of thyroid diseases in the general public.
There are complex signs and symptoms like fatigue, increased sensitivity to cold, constipation, dry skin, weight gain, muscle weakness, slowed heart rate, thinning hair, cholesterol disturbance, irregular menstrual periods, depression, impaired memory. People having these kind of signs usually do not think about thyroid gland malfunction but expect other reasons. Even consulting with primary care physician may result in diagnosis like depression. People often also simply accept it when they are becoming older.
The proposal should specify how the awareness can be increased in general public and help, based on the complexity of symptoms, to specify detection mechanisms and to increase the awareness and to shorten the timeframe until people actually think they could be suffering from thyroid disorders until they get confirmative diagnosis.
The proposals should also cover respective sub-groups at risk: e.g. women during puberty and first menstruation, pregnancy, within the first six months after giving birth, and during menopause.
All proposals will be assessed by our Research & Development organization. Based on the level of interest within our research portfolio, a variety of opportunities ranging from financial support (e.g. success based funding packages), to participation in the development of the idea or tool of the applicant’s proposal are possible.
We anticipate proposals from a wide range of academic as well as spin-off or TTOs with ideas and opportunities how to increase the awareness and how self-diagnostics can be applied and improved to address the issue.
The research team at Merck Biopharma will evaluate the proposals and assess their novelty and feasibility as well as their strategic fit into the company’s long-term focus. Proponents that submit proposals of interest will be contacted within four weeks of submission to clarify additional details concerning the underlying science as well as intellectual property rights, timelines, etc.
Submissions open until December 31st 2016.
A description of the proposal in a form and length that is sufficient to provide the substance of the proposal and its innovativeness. The applicant should also provide information about his or her critical knowledge that is applicable for the project and how that knowledge could be supplemented (i.e., what is additionally required to complete the project). Additional information, including references or other materials should be attached to facilitate the evaluation process.
Proposals may be:
- Solutions which are IP protected and available for (also non-exclusive) licensing and entire IP selling packages
- Collaboration proposals which should include a non-confidential research and development plan including timelines, financials, objectives to address the problem
- General information, which is neither a collaboration proposal nor IP protected solutions however which you consider relevant to share with us.
While Merck will not share the information beyond its own staff, your initial proposal should contain only non-confidential information.
If your proposal is selected, you will be requested to complete a Confidentiality Disclosure Agreement (CDA) and to confirm ability to execute a Materials Transfer Agreement (MTA).
Biowebspin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data.
Merck KGaA is a leading science and technology company in healthcare, life science and performance materials. From developing new therapies that treat and prevent disease to helping people in need, Merck KGaA is committed to improving health and well-being around the world.
Biowebspin is the leading life sciences network with more than 2 million researchers in Biotech, Pharma and Medtech. Biowebspin has a database of 50,000 companies working on 5000 different R&D projects in more than 50 topics, organized in 10 main types of partnering programs with Academia.